I now have all the content needed from both Fishman's and Murray & Nadel's. Let me compile the comprehensive answer.
Hydatid Disease of the Lung
Sources: Fishman's Pulmonary Diseases and Disorders, 2-Volume Set (Chapter 136) and Murray & Nadel's Textbook of Respiratory Medicine, 2-Volume Set (Chapter 58)
Definition
Hydatid disease (cystic echinococcosis, CE) is a zoonotic parasitic infection caused by the larval (metacestode) stage of the tapeworm Echinococcus granulosus, resulting in cyst formation in various organs - most commonly the liver and lungs. It is also called cystic echinococcosis or hydatidosis.
- Fishman's Pulmonary Diseases and Disorders, Ch. 136
Etiology
Causative organism: Echinococcus granulosus (the dog tapeworm) is responsible for the vast majority of pulmonary disease. Four species can infect humans: E. granulosus, E. multilocularis, E. vogeli, and E. oligarthus. E. granulosus has recently been recognized as a complex of 10 distinct genotypes.
Geographic distribution: Worldwide with endemic foci in:
- South America, Australia, eastern Europe
- North Africa, the Middle East, central Asia
- Western China
- Mediterranean basin (Italy, Spain, Albania, former Yugoslavia)
- Central America, sub-Saharan Africa, Russia, China, northern Japan
Life cycle:
- The definitive hosts (domestic dogs, foxes, wolves, and other canids) ingest the hydatid cyst form from infected viscera of intermediate hosts (sheep, pigs, cattle, goats)
- The cyst matures into the adult tapeworm in the canine intestine and sheds embryonated eggs in feces
- Humans are accidental intermediate hosts - infected by ingestion of eggs in contaminated food/water, or by close contact with dogs
- Released embryo oncospheres penetrate the intestinal wall, enter the bloodstream, and travel to the liver or other organs where they mature into metacestode cysts
- The lungs are the second most common site (20%) after the liver (80%)
- Fishman's, Ch. 136; Murray & Nadel's, Ch. 58
Pathogenesis
Cyst structure - three layers (Fig. 136-5):
Figure 136-5 (Fishman's): Lung biopsy of hydatid cyst from E. granulosus demonstrating outer compressed host tissue, middle laminated layer, and a protoscolex arising from the inner germinal layer (H&E stain, 100x)
| Layer | Name | Composition |
|---|
| Outer | Pericyst | Host-derived compressed lung + granulomatous inflammation → fibrosis |
| Middle | Laminated layer | Acellular, parasite-derived |
| Inner | Endocyst / Germinal layer | Produces protoscolices, daughter cysts, and hydatid sand |
Growth and consequences:
-
Cysts grow slowly over years to decades, causing symptoms by mass effect
-
Eventually a cyst may degenerate into a calcified mass
-
A viable cyst may rupture:
- Into bronchial tree: expectoration of cyst material; can become secondarily infected (lung abscess)
- Into pleural space: pneumothorax, effusion, secondary seeding of daughter cysts, or empyema
- Rupture (spontaneous or iatrogenic): the cyst fluid is highly immunogenic, triggering acute hypersensitivity or anaphylactic reactions
-
In children: lung disease is more frequently detected than in adults because the lungs accommodate faster cyst growth due to greater lung elasticity and weaker immune responses
-
Fishman's, Ch. 136; Murray & Nadel's, Ch. 58
Clinical Features
Asymptomatic presentation: Pulmonary hydatid cysts are often asymptomatic and found incidentally on imaging. This is especially true in children, even with very large cysts.
Symptomatic - from cyst compression:
- Cough
- Chest pain
- Dyspnea
- Less often: hemoptysis
- Erosion into adjacent structures: bone pain, hemorrhage, or airway compression
Symptomatic - from cyst rupture (abrupt onset):
- Fever and cough (can have abrupt onset)
- Expectoration of macroscopic parasite fragments - sputum may contain cyst material ("salty water taste")
- Hemoptysis
- Urticaria, wheezing (hypersensitivity)
- Anaphylaxis (can develop, but rarely fatal)
Distribution: Cysts tend to be:
- Unilateral in 50-80% of cases
- Solitary in 60%
- Predilection for the lower lobes
- Up to 35% of individuals have concomitant hepatic involvement
Laboratory findings: Generally non-specific; peripheral eosinophilia is seen in less than 25% of cases.
- Fishman's, Ch. 136; Murray & Nadel's, Ch. 58
Diagnosis
Imaging
Chest radiograph:
- Uncomplicated (unruptured) cysts: well-defined, round or oval homogeneous masses, 1-20 cm in diameter, smooth borders, normal adjacent lung tissue
- If ruptured into a large airway: air-fluid level due to partial discharge of cyst contents
- "Water lily" sign (pathognomonic): Seen when a cyst fully or partially ruptures - air enters the cyst, the endocyst detaches from the pericyst and collapses to float on the remaining fluid - the endocyst appears like a water lily floating on a pond. This sign is rare but pathognomonic of a collapsed hydatid cyst.
- "Meniscus" sign: Crescent of air at the top of the cyst (air between pericyst and endocyst before the endocyst fully detaches)
Figure 58.6 (Murray & Nadel's): (A) Adult E. granulosus; (B) Hepatic cyst; (C) Pulmonary echinococcal cyst on CXR; (D) Ruptured cyst with "water lily" sign
CT scan:
- More useful in complicated cysts
- Defines secondary infection (contrast enhancement around cyst wall)
- Shows communication with bronchial tree
- Reveals presence of daughter cysts within a larger cyst (helps distinguish from other pulmonary cysts)
- CT scan is the imaging of choice for detailed characterization
Ultrasound: Rarely used for pulmonary disease; reserved for pleural disease or cysts adjacent to the thoracic wall.
Serology
- ELISA, indirect hemagglutination, or latex agglutination can be adjunctive
- Sensitivity in pulmonary echinococcosis: only 50-60% (much lower than hepatic disease where sensitivity is 85-98%)
- Serology is therefore confirmatory rather than diagnostic in pulmonary disease
- Positive tests must be confirmed with Western blot for purified antigens (specificity limited by cross-reactivity with other helminth diseases, malignancies, and autoimmune disease)
- Cyst complications or multiorgan involvement are associated with higher seropositivity
Microscopy
- Cyst rupture: examine sputum or pleural fluid for protoscolices (rigid "mouthparts"/scolices) - diagnostic
- Aspirated cyst fluid or surgical histopathology: also diagnostic
- Direct microscopy demonstrating protoscolices or other parasite features is confirmatory
WHO expert consensus guidelines (last updated 2009) summarize key diagnostic and management recommendations.
- Fishman's, Ch. 136; Murray & Nadel's, Ch. 58
Treatment
1. Surgery (Mainstay of Treatment)
Surgery is the principal treatment for patients who can tolerate the procedure and remains the mainstay of therapy for pulmonary hydatid disease.
Goals:
- Remove as much of the cyst as possible while avoiding intraoperative spillage and dissemination
- Confirm the diagnosis
- Treat local complications
Surgical approaches (lung-parenchyma preserving, favored):
- Cyst enucleation
- Cystotomy (Fig. 136-7)
- Removal after aspiration
Recurrence rate with conservative surgery: Less than 2%.
More extensive resection (lobectomy etc.) is reserved for:
- Giant cysts
- Cysts complicated by secondary bacterial abscesses
Intraoperative precautions:
- Hypertonic saline-soaked surgical drapes to protect the operative field (scolicidal agent)
- Intraoperative instillation of hypertonic saline or 1% formaldehyde into the cyst lumen for 15 minutes or more before further manipulation (to minimize consequences of spillage)
- Cavity marsupialization or surgical drain placement after removal
Perioperative medications:
- Preoperative albendazole: reduces consequences of dissemination if intraoperative rupture occurs
- Praziquantel: added particularly if cyst has ruptured (scolicidal effect)
PAIR procedure (Percutaneous Aspiration, Injection, Re-aspiration): Not recommended for pulmonary cysts due to higher complication rates (used for hepatic cysts only).
2. Medical (Chemotherapy) - Benzimidazoles
Medical therapy is reserved for:
- Small, uncomplicated cysts
- When surgery is not feasible
- Perioperative use (pre- and post-operative)
Drug of choice: Albendazole (preferred over mebendazole due to improved bioavailability)
| Drug | Dose | Duration | Notes |
|---|
| Albendazole | 400 mg twice daily | 3 to 6 months | For small uncomplicated cysts; limited cure in pulmonary disease |
| Praziquantel | Added to albendazole | - | Especially if cyst ruptured; scolicidal effect; combination may have greater efficacy than either alone |
| Mebendazole | Previously used | - | Now superseded by albendazole |
Key side effects of albendazole:
- Hepatotoxicity
- Leukopenia
- Hair loss (alopecia)
- GI distress
Important notes:
- Albendazole is curative in only a minority of pulmonary cases when used alone
- Combination of albendazole + praziquantel shows promise of improved efficacy (mainly data in hepatic disease; limited pulmonary data)
- Serial serologic assays have been found to be without value for monitoring treatment response - use clinical findings and imaging instead
E. multilocularis (Alveolar Echinococcosis) - Special Note
(Murray & Nadel's, Ch. 58)
- Rare but potentially fatal
- Liver is the initial target; spreads to lung by metastatic dissemination or direct extension through the diaphragm
- The only cure is radical resection followed by long-term albendazole
- If not amenable to surgery: life-long albendazole may be beneficial
Summary Table
| Feature | Fishman's (Ch. 136) | Murray & Nadel's (Ch. 58) |
|---|
| Commonest species | E. granulosus | E. granulosus |
| Lung involvement | 20% | 20-40% |
| Cyst - unilateral | 50-80% | - |
| Cyst - solitary | 60% | Solitary, one organ in most |
| Eosinophilia | <25% | Not emphasized |
| CXR size | 1-20 cm | 1-20 cm |
| Serology sensitivity (lung) | 50-60% | ~50% |
| Albendazole dose | 400 mg BD x 3-6 months | Not explicitly dosed; prolonged course |
| Surgery recurrence | <2% | Low with proper technique |
| PAIR for lung | Not recommended | Not mentioned for lung |
References:
- Fishman's Pulmonary Diseases and Disorders, 2-Volume Set, Chapter 136 (Pulmonary Echinococcosis/Hydatid Disease), pp. 2424-2426
- Murray & Nadel's Textbook of Respiratory Medicine, 2-Volume Set, Chapter 58 (Cestodes - Echinococcosis), pp. 1349-1351